Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
NCT03961529
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
366
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
0.3% OPA-15406 ointment
DRUG:
1% OPA-15406 ointment
Sponsor
Otsuka Pharmaceutical Co., Ltd.